BPC
BHVN

Banque Pictet & Cie’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Banque Pictet & Cie’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,400
Closed -$1.95M – 696
2022
Q1 		$1.95M Buy
16,400
+636
+4% +$79.3K 0.02% 336
2021
Q4 		$2.17M Buy
+15,764
New +$2M 0.02% 329

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Banque Pictet & Cie's BHVN Position: Q2 2022 in Review

Banque Pictet & Cie sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 16,400 shares — an estimated $1.95M sold.

Banque Pictet & Cie first reported a position in BHVN in Q4 2021 and held it in 2 quarters. The position peaked at $2.17M in Q4 2021. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

  • Banque Pictet & Cie reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
  • Banque Pictet & Cie sold 16,400 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $1.95M.
  • Banque Pictet & Cie first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021 and held it in 2 quarters.
  • Banque Pictet & Cie's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.17M in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on Banque Pictet & Cie's 13F filing for Q2 2022, filed 8 Aug 2022.